Novel strategies for adoptive therapy following HLA disparate transplants

Best Practice and Research: Clinical Haematology

Volumn 24, Issue 3, 2011, Pages 381-391

  O'Reilly, Richard J ^a   Hasan, Aisha ^a   Doubrovina, Ekaterina ^a   Koehne, Guenther ^a   Prockop, Susan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

adoptive T cell therapy; HLA non identical transplants

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ADAPTIVE IMMUNITY; ADOPTIVE IMMUNOTHERAPY; ALLELE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TRANSPLANTATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS INFECTION; HLA HAPLOTYPE DISPARATE TRANSPLANT; HLA MATCHING; HUMAN; LYMPH NODE BIOPSY; LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REMISSION; T CELL DEPLETION; VIRUS IMMUNITY;

EID: 80053038331     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2011.06.001     Document Type: Review

References (53)

1. Y. Reisner, N. Kapoor, and D. Kirkpatrick Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells Lancet 2 1981 327 331 (Pubitemid 11040580)
2. Y. Reisner, N. Kapoor, and D. Kirkpatrick Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood 61 1983 341 348 (Pubitemid 13137655)
3. R.J. O'Reilly, J. Brochstein, and N. Collins Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency Vox Sang 51 Suppl. 2 1986 81 86 (Pubitemid 16011426)
4. R.H. Buckley, S.E. Schiff, and R.I. Schiff Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency N Engl J Med 340 1999 508 516 (Pubitemid 29093286)
5. W. Friedrich, S.F. Goldmann, and W. Ebell Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors Eur J Pediatr 144 1985 125 130 (Pubitemid 15006986)
6. M.J. Cowan, D.W. Wara, and P.S. Weintrub Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells J Clin Immunol 5 1985 370 376 (Pubitemid 16199504)
7. N.A. Kernan, N. Flomenberg, and B. Dupont Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes Transplantation 43 1987 842 847 (Pubitemid 17084261)
8. C. Bordignon, C.A. Keever, and T.N. Small Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms Blood 74 1989 2237 2243 (Pubitemid 19269135)
9. N.A. Kernan, C. Bordignon, and G. Heller Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants Blood 74 1989 2227 2236 (Pubitemid 19269134)
10. A. Green, E. Clarke, and L. Hunt Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome Blood 94 1999 2236 2246 (Pubitemid 29467670)
11. J.W. Young, E.B. Papadopoulos, and I. Cunningham T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission Blood 79 1992 3380 3387
12. E.B. Papadopoulos, M.H. Carabasi, and H. Castro-Malaspina T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease Blood 91 1998 1083 1090 (Pubitemid 28078314)
13. S. Mackinnon, L. Barnett, and J.H. Bourhis Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA Blood 80 1992 3235 3241 (Pubitemid 23004529)
14. E. Bachar-Lustig, N. Rachamim, and H.W. Li Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice Nat Med 1 1995 1268 1273
15. F. Aversa, A. Terenzi, and A. Tabilio Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse J Clin Oncol 23 2005 3447 3454
16. T. Klingebiel, J. Cornish, and M. Labopin Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group Blood 115 2010 3437 3446
17. A.A. Jakubowski, T.N. Small, and J.W. Young T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin Blood 110 2007 4552 4559 (Pubitemid 351377823)
18. R.J. Soiffer, D. Fairclough, and M. Robertson CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission Blood 89 1997 3039 3047 (Pubitemid 27172592)
19. H. Castro-Malaspina, A.A. Jabubowski, and E.B. Papadopoulos Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings Biol Blood Marrow Transplant 14 2008 458 468 (Pubitemid 351372752)
20. K.G. Lucas, T.N. Small, and G. Heller The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation Blood 87 1996 2594 2603 (Pubitemid 26086907)
21. G. Tosato, A.D. Steinberg, and R. Yarchoan Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis J Clin Invest 73 1984 1789 1795 (Pubitemid 14084497)
22. Q.Y. Yao, P. Ogan, and M. Rowe Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers Int J Cancer 43 1989 67 71 (Pubitemid 19039118)
23. L.C. Tan, N. Gudgeon, and N.E. Annels A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers J Immunol 162 1999 1827 1835 (Pubitemid 29307064)
24. S. Bhaduri-McIntosh, M.J. Rotenberg, and B. Gardner Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines Blood 111 2008 1334 1343 (Pubitemid 351213420)
25. N.G. Almyroudis, A. Jakubowski, and D. Jaffe Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation Transpl Infect Dis 9 2007 286 294 (Pubitemid 350059149)
26. M. Boeckh, W. Leisenring, and S.R. Riddell Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity Blood 101 2003 407 414 (Pubitemid 36077556)
27. P. Ljungman Immune reconstitution and viral infections after stem cell transplantation Bone Marrow Transplant 21 Suppl. 2 1998 S72 S74
28. A.E. Broers, R. van Der Holt, and J.W. van Esser Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation Blood 95 2000 2240 2245 (Pubitemid 30167720)
29. C. Suparno, D.W. Milligan, and P.A. Moss Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management Leuk Lymphoma 45 2004 873 885 (Pubitemid 38444663)
30. S. Chakrabarti, D.W. Milligan, and J. Brown Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens Bone Marrow Transplant 33 2004 197 204 (Pubitemid 38180933)
31. J.A. van Burik, S.L. Carter, and A.G. Freifeld Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease Biol Blood Marrow Transplant 13 2007 1487 1498 (Pubitemid 350091387)
32. T.N. Small, D. Avigan, and B. Dupont Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis Biol Blood Marrow Transplant 3 1997 65 75 (Pubitemid 127529979)
33. T.N. Small, E.B. Papadopoulos, and F. Boulad Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions Blood 93 1999 467 480 (Pubitemid 29035728)
34. C.A. Keever-Taylor, J.E. Wagner, and N.A. Kernan Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II-III trial (T-cell depletion trial) Bone Marrow Transplant 45 2010 587 589
35. R.J. O'Reilly, E. Doubrovina, and D. Trivedi Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants Immunol Res 38 2007 237 250 (Pubitemid 47574910)
36. G. Koehne, E. Doubrovina, and A. Hasan A phase I dose Escalation trial of donor T cells sensitized with pentadecapeptides of the CMV-pp65 protein for the treatment of CMV infections following allogeneic hematopoietic stem cell transplants ASH Annu Meet Abstr 114 2009 891
37. D. Trivedi, R.Y. Williams, and R.J. O'Reilly Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy Blood 105 2005 2793 2801 (Pubitemid 40446272)
38. M.F. Callan, C. Fazou, and H. Yang CD8(+) T-cell selection, function, and death in the primary immune response in vivo J Clin Invest 106 2000 1251 1261
39. A.D. Hislop, N.E. Annels, and N.H. Gudgeon Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection J Exp Med 195 2002 893 905 (Pubitemid 34286760)
40. N. Khan, D. Best, and R. Bruton T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection J Immunol 178 2007 4455 4465 (Pubitemid 46492397)
41. D.A. Price, J.M. Brenchley, and L.E. Ruff Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses J Exp Med 202 2005 1349 1361 (Pubitemid 41668738)
42. S.R. Lewin, G. Heller, and L. Zhang Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations Blood 100 2002 2235 2242 (Pubitemid 35001261)
43. J.B. Latouche, and M. Sadelain Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells Nat Biotechnol 18 2000 405 409 (Pubitemid 30217527)
44. J. Dupont, J.B. Latouche, and C. Ma Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells Cancer Res 65 2005 5417 5427 (Pubitemid 40827355)
45. G.A. Papanicolaou, J.B. Latouche, and C. Tan Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele Blood 102 2003 2498 2505 (Pubitemid 37193588)
46. A.N. Hasan, W.J. Kollen, and D. Trivedi A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy J Immunol 183 2009 2837 2850
47. M. Kozak At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells J Mol Biol 196 1987 947 950
48. S.F. Lacey, M.C. Villacres, and C. La Rosa Relative dominance of HLA-B07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A02 and HLA-B07 alleles Hum Immunol 64 2003 440 452 (Pubitemid 36373774)
49. T. Haque, G.M. Wilkie, and C. Taylor Treatment of Epstein-Barr-virus- positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells Lancet 360 2002 436 442 (Pubitemid 34880139)
50. T. Haque, G.M. Wilkie, and M.M. Jones Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial Blood 110 2007 1123 1131 (Pubitemid 47281407)
51. E.B. Papadopoulos, M. Ladanyi, and D. Emanuel Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation N Engl J Med 330 1994 1185 1191 (Pubitemid 24121987)
52. R.J. O'Reilly, T.N. Small, and E. Papadopoulos Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts Immunol Rev 157 1997 195 216 (Pubitemid 27303130)
53. J.N. Barker, E. Doubrovina, and C. Sauter Successful treatment of Epstein-Barr virus (EBV)-associated post-transplant lymphoma after cord blood transplant using third-party EBV-specific cytotoxic T-lymphocytes Blood 116 2010 5045 5049